Evidence map›Paper›PMID 40590677›Full record

ArticleEuropean journal of neurology2025

Cerebral Cavernous Malformations and Focal Drug-Resistant Epilepsy: Behind a Quid Pro Quo of Lesion and Epileptogenic Networks.

Ionuț-Flavius Bratu, Lucie de Clerck, Hélène Catenoix, Luc Valton, Jérôme Aupy, Anca Nica, Sylvain Rheims, Sandrine Aubert-Conil, Jeanne Benoit, Julia Makhalova and 3 more

Abstract readMulticenter Study
In one paragraph

Article in European journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ionuț-Flavius BratuDepartment of Epileptology and Cerebral Rhythmology, Timone Hospital, Marseille, France.ORCID 0000-0002-8978-8927
Lucie de ClerckDepartment of Epileptology and Cerebral Rhythmology, Timone Hospital, Marseille, France.
Hélène CatenoixDepartment of Functional Neurology and Epileptology, Hospices Civils de Lyon and Lyon 1 University, Lyon, France.
Luc ValtonDepartment of Neurology, Toulouse University Hospital, Toulouse, France.
Jérôme AupyDepartment of Clinical Neurosciences, Bordeaux University Hospital, Bordeaux, France.
Anca NicaDepartment of Neurology, Clinical Research Center Rennes, CIC 1414, Rennes University Hospital, Rennes, France.
Sylvain RheimsDepartment of Functional Neurology and Epileptology, Hospices Civils de Lyon and Lyon 1 University, Lyon, France.ORCID 0000-0002-4663-8515
Sandrine Aubert-ConilDepartment of Epileptology and Cerebral Rhythmology, Timone Hospital, Marseille, France.
Jeanne BenoitSystems Neuroscience Institute, Aix-Marseille University, French National Institute of Health and Medical Research (UMR 1106), Marseille, France.
Julia MakhalovaDepartment of Epileptology and Cerebral Rhythmology, Timone Hospital, Marseille, France.
Ophélie GalliDepartment of Epileptology and Cerebral Rhythmology, Timone Hospital, Marseille, France.
Samuel Medina VillalonDepartment of Epileptology and Cerebral Rhythmology, Timone Hospital, Marseille, France.
Fabrice BartolomeiDepartment of Epileptology and Cerebral Rhythmology, Timone Hospital, Marseille, France.

Funding

Agence Nationale de la Recherche ANR-16-CONV000XAgence Nationale de la Recherche ANR-17-EURE-0029Agence Nationale de la Recherche ANR-19-CE37-0027Excellence Initiative of Aix-Marseille University AMX-19-IET-004
6 · The paper itself

Abstract

backgroundCerebral cavernous malformations (CCMs) contribute to focal drug-resistant epilepsy (fDRE), with surgical outcomes varying due to an incomplete understanding of the interplay between CCM-impacted regions and areas exhibiting ictal or interictal epileptogenicity. This study quantified the epileptogenicity of brain structures sampled by stereo-electroencephalography (SEEG) electrodes in patients with fDRE and supratentorial CCMs, focusing on the irritative zone (IZN) and epileptogenic-zone network (EZN). It also established a framework for describing EZN organization relative to CCM-affected regions.

methodsRetrospective multicentric cohort study involving fDRE patients with supratentorial CCMs, explored using SEEG, recruited from five French tertiary epilepsy centers. SEEG-sampled brain regions were classified as lesional, perilesional, or non-lesion-associated according to their anatomic relationship with the CCMs and using the Virtual Epileptic Patient brain atlas parcellation. IZN quantification was performed using spike rates per minute. EZN was evaluated using the Epileptogenicity Index or Permutation Entropy Index according to the seizure-onset pattern. Data were analyzed using both descriptive and inferential statistics.

resultsThe study included 22 patients, 10 of whom underwent post-SEEG epilepsy surgery. IZN biomarkers differed significantly between lesional, perilesional, and non-lesion-associated areas, whereas EZN biomarkers did not. EZN included lesional areas in 50% of cases, with complex multi-lobar networks identified in most patients. Postsurgical seizure freedom was achieved in 70% of SEEG-explored patients.

conclusionsOur findings highlight the complex relationship between CCMs and the EZN, supporting SEEG in the presurgical work-up of selected patients with CCMs and fDRE. A network-based surgical approach may improve outcomes by tailoring resections to the EZN.

Indexed as

BrainDrug Resistant EpilepsyHemangioma, Cavernous, Central Nervous SystemNerve NetAdolescentAdultCohort StudiesElectroencephalographyFemaleHumansMaleMiddle AgedRetrospective StudiesYoung Adultcerebral cavernous malformationsEpileptogenicity Indexepileptogenic networksPermutation Entropy IndexSEEG

Identifiers

PMID40590677
PMCPMC12210390

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.